AbbVie Lowers FY2026 Adj EPS Guidance from $14.08-$14.28 to $13.87-$14.07 vs $14.08 Est
AbbVie (NYSE: ABBV ) lowers FY2026 Adj EPS guidance from $14.08-$14.28 to $13.87-$14.07 vs $14.08 analyst estimate..
Story updates
12:21:44 PM UTC
SquawkNews
AbbVie (NYSE: ABBV ) lowers FY2026 Adj EPS guidance from $13.91-$14.11 to $13.87-$14.07 vs $14.08 analyst estimate..
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.